Clarivate Plc (CLVT)
| Market Cap | 1.06B -54.3% |
| Revenue (ttm) | 2.41B -3.5% |
| Net Income | -334.00M |
| EPS | -0.51 |
| Shares Out | 639.66M |
| PE Ratio | n/a |
| Forward PE | 2.41 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4,153,058 |
| Open | 1.690 |
| Previous Close | 1.720 |
| Day's Range | 1.610 - 1.715 |
| 52-Week Range | 1.420 - 3.870 |
| Beta | 1.40 |
| Analysts | Hold |
| Price Target | 2.97 (+79.82%) |
| Earnings Date | Nov 3, 2026 |
About CLVT
Clarivate Plc provides information services in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Intellectual Property, and Life Sciences & Healthcare. The company offers scientific and academic research solutions; Web of Science Research Intelligence, an AI-native solution; ProQuest solutions to access multidisciplinary curated content, such as databases, dissertations, news, primary sources, books, and video formats; library software, including Alma, library service... [Read more]
Financial Performance
In 2025, Clarivate's revenue was $2.46 billion, a decrease of -3.97% compared to the previous year's $2.56 billion. Losses were -$201.10 million, -69.90% less than in 2024.
Financial StatementsAnalyst Summary
According to 9 analysts, the average rating for CLVT stock is "Hold." The 12-month stock price target is $2.97, which is an increase of 79.82% from the latest price.
News
Clarivate resumed with an Underweight at Morgan Stanley
Morgan Stanley analyst Toni Kaplan resumed coverage of Clarivate (CLVT) with an Underweight rating and $1.50 price target The firm expects organic growth to remain modest and below peers, leading…
Clarivate Demonstrates Global Demand For AI-native Web Of Science Research Intelligence
More than 100 institutions across 25 countries and regions are using the AI-native research intelligence platform. LONDON, Oct. 22, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global pr...
Sterne Kessler and Clarivate Announce Partnership to Develop AI-enhanced Patent Workflow Solutions
WASHINGTON--(BUSINESS WIRE)--Sterne, Kessler, Goldstein & Fox (Sterne Kessler), a market leading intellectual property (IP) law firm, today announced a co-development partnership with Clarivate Plc (N...
Clarivate Completes Sale of Life Sciences & Healthcare Segment, Advances Strategic Transformation
Transaction sharpens strategic focus on leading Academia & Government and Intellectual Property segments Proceeds strengthen balance sheet and enhance financial flexibility LONDON, Oct. 6, 2026 /PRNew...
Clarivate Announces Final Results of Offer to Purchase for Cash Certain of its Outstanding Debt Securities
LONDON, Sept. 24, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced the expiration and final results of its previ...
Clarivate Announces Pricing Terms of Offer to Purchase for Cash Certain of its Outstanding Debt Securities
LONDON, Sept. 23, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced the Reference Yield and Total Consideration (...
Clarivate to Report Third Quarter 2026 Results on November 3, 2026
LONDON, Sept. 22, 2026 /PRNewswire/ -- (PR Newswire) - Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced it will report its financial results for th...
Clarivate Commences Offer to Purchase for Cash Certain of its Outstanding Debt Securities
NEW YORK, Sept. 17, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced that its wholly-owned subsidiary, Clarivate...
Clarivate Reveals Citation Laureates 2026 Recognizing Transformative Scientific Breakthroughs
22 researchers honored for Nobel-class discoveries, including pioneers of GLP-1 medicines and other world-changing advances LONDON, Sept. 17, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading...
Accuserve Solutions Appoints Maroun S. Mourad as an Independent Board Member
Veteran Insurance Executive Brings Carrier Relationships and Data Analytics Expertise to Support Accuserve's Continued Growth and Its Mission to Simplify the Claims Experience DENVER, Sept. 01, 2026 ...
Clarivate Scales Agentic AI Across Cortellis to Advance Drug Development
Expanded capabilities across Cortellis portfolio help life sciences organizations turn trusted intelligence into action and accelerate decision making across the research and development lifecycle LON...
Clarivate price target lowered to $5 from $6 at Stifel
Stifel lowered the firm’s price target on Clarivate (CLVT) to $5 from $6 and keeps a Buy rating on the shares.
Clarivate price target lowered to $2.50 from $2.80 at Citi
Citi analyst Peter Christiansen lowered the firm’s price target on Clarivate (CLVT) to $2.50 from $2.80 and keeps a Neutral rating on the shares.
Clarivate price target lowered to $2.60 from $2.90 at Goldman Sachs
Goldman Sachs lowered the firm’s price target on Clarivate (CLVT) to $2.60 from $2.90 and keeps a Buy rating on the shares.
Clarivate price target lowered to $2 from $2.50 at Barclays
Barclays analyst Manav Patnaik lowered the firm’s price target on Clarivate (CLVT) to $2 from $2.50 and keeps an Underweight rating on the shares. The firm says the company “rebuilding…
Clarivate Earnings Call Transcript: Q2 2026
AI-driven innovation and portfolio optimization drove recurring revenue growth and margin expansion, despite lower transactional revenues and the impact of disposals. Guidance remains strong, with sequential organic growth and further debt reduction expected in the second half.
Clarivate Earnings release: Q2 2026
Clarivate released its Q2 2026 earnings on July 29, 2026, summarizing the period's financial results.
Clarivate Quarterly report: Q2 2026
Clarivate has published its Q2 2026 quarterly earnings report on July 29, 2026.
Clarivate Slides: Q2 2026
Clarivate has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 29, 2026.
Clarivate CFO Jonathan Collins to step down, Michael Easton to succeed
Clarivate (CLVT) announced the appointment of Michael Easton as executive VP and CFO, effective August 8. He succeeds Jonathan Collins who is stepping down as CFO to pursue another opportunity.
Clarivate reports Q2 adjusted EPS 19c, consensus 18c
Reports Q2 revenue $587.3M, consensus $589.76M. The company said, “The Value Creation Plan continues to drive meaningful progress, as we execute against our strategic priorities and strengthen Clariva...
Clarivate backs FY26 adjusted EPS view 70c-80c, consensus 73c
Backs FY26 revenue view $2.3B-$2.42B, consensus $2.18B. Backs FY26 adjusted EBITDA view $980M-$1.04B. The company said, “Our second quarter results reflect continued financial discipline and execution...
Clarivate Appoints Michael Easton as Chief Financial Officer
Experienced Clarivate leader brings more than 25 years of financial and operational expertise LONDON, July 29, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) ("Clarivate" or the "Company"), a leading...
Clarivate Reports Second Quarter 2026 Results
— Delivers continued progress on strategic and financial priorities through Value Creation Plan —— Sharpens focus and enhances financial profile with previously announced Life Sciences & Healthcare se...
Clarivate RiskMark Wins 2026 CODiE Award for Best AI Tool for Lawyers
Prestigious awards program recognizes innovative AI technology transforming trademark risk assessment for legal professionals LONDON, July 20, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leadin...